Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cannara Biotech Inc. LOVFF


Primary Symbol: V.LOVE

Healthcare Cannabis
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company... see more

Recent & Breaking News (TSXV:LOVE)

Cannara Biotech (TSXV:LOVE) enters B.C. market & launches its 1st vape cartridge & accessory

Jonathon Brown September 20, 2022

Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark

PR Newswire September 20, 2022

Acquisition of Common Shares of Cannara Biotech Inc.

PR Newswire September 1, 2022

Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022

PR Newswire August 10, 2022

Cannara signs an Exclusive Brand Partnership with Exotic Genetix in Canada

PR Newswire August 3, 2022

Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results

PR Newswire July 27, 2022

Cannara Biotech Inc. Closes $50 Million Credit Facility Led by BMO Commercial Banking

PR Newswire June 1, 2022

Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services

PR Newswire May 4, 2022

Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results

PR Newswire April 27, 2022

Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

PR Newswire January 20, 2022

Cannara Biotech Inc. to Webcast Live at VirtualInvestorConferences.com on January 20, 2022

PR Newswire January 18, 2022

Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results

PR Newswire December 8, 2021

Cannara Biotech Inc. upsizes CIBC Credit Facility to $22 Million

PR Newswire December 1, 2021

Cannara's Valleyfield Facility Receives Processing and Cultivation License

PR Newswire September 27, 2021

Cannara Biotech Inc. Receives Amendment of its Licence from Health Canada Permitting the Sale of Cannabis 2.0 Products and Prepares for the Launch of its Hash Product Line in Quebec

PR Newswire September 2, 2021

TSX Venture Exchange, Cannara Biotech Inc., C-Suite at The Open

PR Newswire August 10, 2021

The StockTalk Cannabis Report: July 30, 2021

Dave Jackson July 30, 2021

Cannara Biotech Reports Strong Q3 Results

John Ballem  July 29, 2021

Cannara Biotech Inc. Reports Strong First Quarterly Profit Driven by Retail Debut

PR Newswire July 28, 2021

Cannara Biotech Inc. Completes Additional $5 Million Private Placement

PR Newswire July 9, 2021